Penserra Capital Management LLC Medpace Holdings, Inc. Transaction History

Penserra Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $835,179 - $1.07 Million	4,460 New	4,460 $1.07 Million
Q4 2021 Feb 15, 2022	SELL	$182.74 - $227.9 $149,846 - $186,878	-820 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $624,560 - $727,430	-3,670 Reduced 81.74%	820 $155,000
Q2 2021 Aug 12, 2021	BUY	$158.62 - $194.3 $584,514 - $715,995	3,685 Added 457.76%	4,490 $792,000
Q1 2021 May 13, 2021	SELL	$132.02 - $168.26 $1,980 - $2,523	-15 Reduced 1.83%	805 $132,000

Q4 2020 Feb 12, 2021	BUY	$109.38 - $149.19 $56,658 - $77,280	518 Added 171.52%	820 $114,000
Q3 2020 Nov 13, 2020	BUY	$92.95 - $130.61 $28,070 - $39,444	302 New	302 $33,000
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $573,324 - $692,439	-8,181 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$62.38 - $85.89 $510,330 - $702,666	8,181 New	8,181 $687,000
Q1 2019 May 08, 2019	SELL	$49.38 - $70.58 $10.6 Million - $15.2 Million	-215,145 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$46.97 - $63.98 $3.42 Million - $4.66 Million	-72,904 Reduced 25.31%	215,145 $11.4 Million
Q3 2018 Nov 05, 2018	BUY	$43.25 - $63.74 $12.5 Million - $18.4 Million	288,049 New	288,049 $17.3 Million

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.